Discover 1,092 paid clinical trials in South Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
South Carolina has a wide range of paid research studies actively seeking both healthy volunteers and those with particular health conditions. Major hubs in Charleston, Columbia, and Greenville provide access to innovative treatments and top-quality medical care.
Filter
1
Filter results
Results: 1,092
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Brewer ME, Augusta ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase2, Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Boston MA, New Haven CT, Stony Brook NY, Lake Sucess NY,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT01351545
Recruiting
Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL
for
B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
Location: Charleston SC
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT05702853
Phase1, Phase2, Recruiting
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
for
End Stage Renal Disease
Location: Boston MA, Roanoke VA, Columbia SC, Sarasota FL,
Sponsor: Laminate Medical Technologies
Sex: All
Age: 18 - 70+
Code: NCT06516653
Recruiting
A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems
Get alerts for new trials in your area by subscribing now
Platform of Randomized Adaptive Clinical Trials in Critical Illness
for
Respiratory Insufficiency,
Location: Halifax, Providence RI, Sherbrooke, New York NY,
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT05440851
Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
for
Metastatic Salivary Gland Carcinoma,
Location: Boston MA, Lebanon NH, Commack NY, Uniondale NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05408845
Phase2, Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
for
Atrial Fibrillation
Location: Scarborough ME, Boston MA, Providence RI, Burlington MA,
Sponsor: Johns Hopkins University
Sex: All
Age: 22 - 70+
Code: NCT05836987
Phase3, Recruiting
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
for
Hematopoietic Cell Transplant, Solid Organ Transplant,
Location: Boston MA, The Bronx NY, Washington D.C. DC, Miami FL,
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0 - 18
Code: NCT05550298
Recruiting
Modulating Anxious Coping
for
Anxiety Disorders
Location: Charleston SC
Sponsor: Medical University of South Carolina
Sex: All
Age: 18 - 65
Code: NCT04824105
Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
for
Prediabetic State, Atherosclerosis, Metformin
Location: Boston MA, West Haven CT, New York NY, Baltimore MD,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT02915198
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for
Myelofibrosis
Location: Boston MA, New Haven CT, The Bronx NY, New York NY,
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 18+
Code: NCT04176198
Phase1, Phase2, Recruiting
MEP Up-conditioning to Target Corticospinal Plasticity
for
Spinal Cord Injury, Tetraplegia/Tetraparesis
Location: Charleston SC
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT06989905
Early_phase1, Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Boston MA, Baltimore MD, Washington D.C. DC, Fairfax VA,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06095505
Phase2, Recruiting
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Location: The Bronx NY, Norfolk VA, Rockville MD, Miami FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 6 - 17
Code: NCT05723198
Phase3, Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: New Haven CT, New York NY, Livingston NJ,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06830798
Phase3, Recruiting
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Scarborough ME, Boston MA, Hartford CT, Sherbrooke,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 21
Code: NCT06064097
Phase2, Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
for
Multiple Myeloma
Location: Halifax, Boston MA, New Haven CT, Sherbrooke,
Sponsor: European Myeloma Network B.V.
Sex: All
Age: 18+
Code: NCT05243797
Phase3, Recruiting
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
for
Arterial Disease of Legs, Below-the-knee Obstruction,
Location: Lake Success NY, Valhalla NY, New York NY,
Sponsor: Concept Medical Inc.
Sex: All
Age: 21+
Code: NCT06182397
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: North Dartmouth MA, Quebec, Toms River NJ,